Multiresistant Gram-negative infections: a global perspective.
about
Prevalence and genotypic relatedness of carbapenem resistance among multidrug-resistant P. aeruginosa in tertiary hospitals across ThailandOn the role of NMR spectroscopy for characterization of antimicrobial peptidesComparative Sequence, Structure and Redox Analyses of Klebsiella pneumoniae DsbA Show That Anti-Virulence Target DsbA Enzymes Fall into Distinct ClassesEpidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacter baumannii infections among solid organ transplant recipientsX-box binding protein 1 (XBP1s) is a critical determinant of Pseudomonas aeruginosa homoserine lactone-mediated apoptosisChemical interference with iron transport systems to suppress bacterial growth of Streptococcus pneumoniaeThe changing burden of infectious disease in Europe.Could chloramphenicol be used against ESKAPE pathogens? A review of in vitro data in the literature from the 21st century.Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia.Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trialThe management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections.Use of imipenem to detect KPC, NDM, OXA, IMP, and VIM carbapenemase activity from gram-negative rods in 75 minutes using liquid chromatography-tandem mass spectrometryTh17 cells mediate clade-specific, serotype-independent mucosal immunityPolicy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS).2013 WSES guidelines for management of intra-abdominal infections.Overcoming drug resistance with alginate oligosaccharides able to potentiate the action of selected antibiotics.Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis.Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem.WSES consensus conference: Guidelines for first-line management of intra-abdominal infections.Crystal structures of Klebsiella pneumoniae dihydrofolate reductase bound to propargyl-linked antifolates reveal features for potency and selectivity.A method for generating marker-less gene deletions in multidrug-resistant Acinetobacter baumannii.Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumanniiMultidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogensEvaluation of Gallium Citrate Formulations against a Multidrug-Resistant Strain of Klebsiella pneumoniae in a Murine Wound Model of Infection.Colonization with resistant microorganisms in patients transferred from abroad: who needs to be screened?In vitro activity of telavancin in combination with colistin versus Gram-negative bacterial pathogens.Iron transport-mediated drug delivery: practical syntheses and in vitro antibacterial studies of tris-catecholate siderophore-aminopenicillin conjugates reveals selectively potent antipseudomonal activityThe combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an in vitro pharmacokinetic/pharmacodynamic modelIntrapulmonary G-CSF rescues neutrophil recruitment to the lung and neutrophil release to blood in Gram-negative bacterial infection in MCP-1-/- mice.Synthesis and characterization of the 47-residue heterodimeric antimicrobial peptide distinctin, featuring directed disulfide bridge formationNetwork Analysis Reveals Sex- and Antibiotic Resistance-Associated Antivirulence Targets in Clinical UropathogensRisk of acquiring extended-spectrum β-lactamase-producing Klebsiella species and Escherichia coli from prior room occupants in the intensive care unit.Inpatient treatment of community-acquired pneumonias with integrative medicine.Treatment and prevention of urinary tract infection with orally active FimH inhibitors.The Increasing Challenge of Multidrug-Resistant Gram-Negative Bacilli: Results of a 5-Year Active Surveillance Program in a Neonatal Intensive Care UnitSystematic Review of Antibiotic Resistance Rates Among Gram-Negative Bacteria in Children With Sepsis in Resource-Limited Countries.Extended infusion of beta-lactam antibiotics: optimizing therapy in critically-ill patients in the era of antimicrobial resistance.Hybrid antibiotics - clinical progress and novel designs.Mechanism of Escherichia coli resistance to Pyrrhocoricin.Recycling antibiotics into GUMBOS: a new combination strategy to combat multi-drug-resistant bacteria.
P2860
Q21245791-40C042CF-8778-44F9-BE5E-C9922BE4F4E0Q26830116-7FEC32B0-E449-4C6B-84B7-12CB91E2AC48Q27680624-6F88FDA5-8BB1-42A0-B0CB-C879D26E710EQ28484482-517269EE-3AC3-46C5-AE9B-B32ADCF50652Q28535497-BB00742C-CB75-4ED2-9338-A03C834B35F6Q28542656-B9B1789F-1694-4CC5-8C73-3A4AFC172486Q30318298-3CFB03B4-89D0-4DAE-8764-63E8ED05A94FQ30726683-682C299B-C418-4A60-848D-F9C97474DC90Q33598276-639C015B-12A5-4D92-8CC8-B2B48E32E700Q33632050-2CB76E52-61CB-4680-97C4-B4095DA73C64Q33892834-35FE4EFD-F36D-4380-B422-968507D798F5Q33900038-B174C3E4-F5C1-441F-A0A7-D315365E49B0Q34242697-D0066EAB-F77F-4490-A21B-FE117F4AE407Q34261329-A7127B89-9D77-4F5F-B161-19C784A5FB59Q34321150-8ED6E418-AEFC-4371-8B70-DB1590BEC7CDQ34348698-5CDFA8F3-D4BB-45FC-9CD8-EA4E63D00809Q34446914-0625D6CB-EF2A-49A1-89D7-E37239152B6BQ34514304-B5D0E12B-17E9-4FC6-B5DA-684BCF8D2727Q34541183-EF4C1B9D-E37F-49AD-A1A8-E601F24C3FB1Q34597438-1C5F149D-919D-4A49-A511-975768660861Q34815029-133F06D3-7A69-4A78-82FD-0F6DC4A355A5Q35168931-86A1E7D9-647C-4067-B9A0-438E2DCB6DB8Q35561864-455E0182-31DE-41A0-85BA-0EC1C0994F93Q35736631-A713D532-4603-4F70-926C-019B3C38843DQ35888780-1BC6FD1A-64C5-4520-9F08-930CB1B3FC03Q36018796-3527A87C-357E-42F3-8E69-58482BB70673Q36049344-A5C14EFF-ABDE-4B5D-9491-CC3524E603BDQ36276852-8D57792B-6483-4468-9517-89CE4D589B1CQ36456860-F90E99C2-5717-42EC-A319-19BE02BC01EAQ36551845-ECD9B349-8AB7-450D-AC6A-F7FFD2261684Q36677371-590A81C3-64AC-494C-8F6C-CD644D84C43CQ36862658-B990A8A9-7CFA-4236-9CF5-E30859E671E3Q36907878-C2BB1E0F-3C35-4035-9BE1-50312976164EQ36961034-3236BE2D-D993-4A08-8DF6-A68A71D7190AQ37207097-56E4765E-F2DB-4C68-ACC6-32DD0F625986Q38592904-5715018B-23DB-4AC3-BBAF-C7B2BF460757Q38705266-D19EE671-E8D8-4D09-8E01-B272AA88B53BQ38832367-7DF25641-E636-483B-AB90-D256F277B043Q38848631-567918C2-592B-483A-B590-9A5B321F7782Q38888005-1E76BA09-E7FE-4444-8685-D724993881C6
P2860
Multiresistant Gram-negative infections: a global perspective.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Multiresistant Gram-negative infections: a global perspective.
@en
Multiresistant Gram-negative infections: a global perspective.
@nl
type
label
Multiresistant Gram-negative infections: a global perspective.
@en
Multiresistant Gram-negative infections: a global perspective.
@nl
prefLabel
Multiresistant Gram-negative infections: a global perspective.
@en
Multiresistant Gram-negative infections: a global perspective.
@nl
P1476
Multiresistant Gram-negative infections: a global perspective.
@en
P2093
Jennifer Ho
Paul A Tambyah
P304
P356
10.1097/QCO.0B013E32833F0D3E
P577
2010-12-01T00:00:00Z